LGND

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Ligand Pharmaceuticals Incorporated

NASDAQ | LGND

185.25

USD

$0.00

(

0.00%

)

At Close (As of Oct 23, 2025)

$3.62B

Market Cap

-

P/E Ratio

-4.05

EPS

$187.81

52 Week High

$93.58

52 Week Low

HEALTHCARE

Sector

LGND Chart

Recent Chart
Price Action

LGND Technicals

Tags:

LGND Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $156M
Total Revenue $167M
Cost Of Revenue $11M
Costof Goods And Services Sold $11M
Operating Income -$23M
Selling General And Administrative $79M
Research And Development $21M
Operating Expenses $179M
Investment Income Net -
Net Interest Income $5M
Interest Income $8.1M
Interest Expense $3M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $35M
Income Before Tax $2.5M
Income Tax Expense $6.6M
Interest And Debt Expense -
Net Income From Continuing Operations -$4M
Comprehensive Income Net Of Tax -
Ebit $5.6M
Ebitda $41M
Net Income -$4M

Revenue & Profitability

Earnings Performance

LGND Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $942M
Total Current Assets $332M
Cash And Cash Equivalents At Carrying Value $72M
Cash And Short Term Investments $72M
Inventory $14M
Current Net Receivables $42M
Total Non Current Assets $610M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $267M
Intangible Assets Excluding Goodwill $267M
Goodwill $105M
Investments -
Long Term Investments $196M
Short Term Investments $184M
Other Current Assets $19M
Other Non Current Assets -
Total Liabilities $111M
Total Current Liabilities $37M
Current Accounts Payable $5.2M
Deferred Revenue -
Current Debt -
Short Term Debt $2.6M
Total Non Current Liabilities $74M
Capital Lease Obligations $7.1M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $7.1M
Other Current Liabilities $26M
Other Non Current Liabilities $18M
Total Shareholder Equity $830M
Treasury Stock -
Retained Earnings $499M
Common Stock $20K
Common Stock Shares Outstanding $18M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $97M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $38M
Capital Expenditures $1.8M
Change In Receivables -
Change In Inventory $9.6M
Profit Loss -
Cashflow From Investment -$144M
Cashflow From Financing $98M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$5.1M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$4M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $156M
Total Revenue $167M
Cost Of Revenue $11M
Costof Goods And Services Sold $11M
Operating Income -$23M
Selling General And Administrative $79M
Research And Development $21M
Operating Expenses $179M
Investment Income Net -
Net Interest Income $5M
Interest Income $8.1M
Interest Expense $3M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $35M
Income Before Tax $2.5M
Income Tax Expense $6.6M
Interest And Debt Expense -
Net Income From Continuing Operations -$4M
Comprehensive Income Net Of Tax -
Ebit $5.6M
Ebitda $41M
Net Income -$4M

Dividends

Field Value
Ex Dividend Date 2010-07-02
Declaration Date None
Record Date None
Payment Date None
Amount 0.08

LGND News

LGND Profile

Ligand Pharmaceuticals Incorporated Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Ligand Pharmaceuticals Incorporated is a prominent biopharmaceutical company based in San Diego, California, dedicated to advancing drug discovery and development through its innovative technologies tailored for pharmaceutical partners worldwide. The company's extensive portfolio of proprietary solutions enables it to enhance drug efficacy and streamline market access across various therapeutic areas. With a strategic focus on collaboration and a seasoned management team, Ligand is uniquely positioned to capitalize on emerging opportunities within the dynamic pharmaceutical sector while fostering sustainable growth and operational excellence.

YYAI
-50.60%
$0.09
BYND
-20.67%
$2.84
SCNX
+354.94%
$2.60
YDKG
+5.58%
$0.07
F
-0.72%
$12.34
CGBS
-39.47%
$0.03
VHAI
0.00%
$0.00
RGTI
+9.80%
$39.59
AIRE
+38.18%
$0.98
RIG
+13.74%
$3.89
TSLA
+2.28%
$448.98
INTC
+3.35%
$38.15
BURU
-5.27%
$0.34
VTYX
+70.98%
$6.60
NOK
+11.17%
$6.17
QBTS
+13.81%
$31.06
NVDA
+1.04%
$182.16
T
-3.63%
$24.62
ADAP
-3.44%
$0.07
MSAI
+101.73%
$1.35
AAL
+5.62%
$12.77
BITF
+5.71%
$4.16
VIVK
+5.68%
$0.26
WTO
-7.04%
$0.06
IONZ
-14.59%
$3.98
AREB
+75.34%
$3.77
AXDX
-61.36%
$0.03
DNN
+0.36%
$2.73
IONQ
+7.06%
$59.37
PLUG
-1.36%
$2.88
ABEV
+0.45%
$2.21
SMCI
-8.72%
$47.92
QUBT
+7.19%
$15.94
TLRY
+2.06%
$1.48
VZ
-3.51%
$38.40
RGTZ
-20.27%
$14.90
GRAB
+1.77%
$5.72
SOFI
+3.27%
$28.08
RBNE
+7.87%
$1.37
BBD
+1.51%
$3.35
JOBY
+1.29%
$15.67
RF
-0.04%
$24.10
CAN
+3.22%
$1.76
ETHD
-3.17%
$3.97
ACHR
+0.46%
$10.91
QS
+7.95%
$14.66
RMBL
+60.50%
$3.21
SGBX
+29.82%
$2.96
AMD
+2.06%
$234.99
BTG
+0.38%
$5.23
ADD
-25.47%
$0.05
VLY
+4.24%
$10.56
ONDS
+4.74%
$7.06
GPUS
-0.28%
$0.38
PLTR
+2.84%
$180.48
LAES
+5.92%
$5.72
RXRX
-0.34%
$5.73
SRM
+53.27%
$10.30
CIFR
+7.10%
$17.25
PFE
-0.20%
$24.67
TNGX
-13.04%
$7.53
UUUU
-6.50%
$21.26
BTBT
+3.62%
$3.72
AAPL
+0.43%
$259.58
MARA
+0.36%
$19.22
AMC
-0.72%
$2.73
DVLT
+5.14%
$2.25
WBD
+3.50%
$21.25
AMZN
+1.44%
$221.09
IREN
+7.77%
$55.86
HPE
+0.43%
$23.19
PBR
+0.93%
$11.84
NIO
+0.73%
$6.89
IBIO
-8.63%
$1.27
CUTR
-10.19%
$0.09
KMI
-4.75%
$26.25
NVTS
+0.03%
$13.61
WLGS
-5.57%
$0.04
SOUN
+2.70%
$18.23
LUV
-6.25%
$31.65
RR
+7.11%
$5.42
TE
-9.73%
$3.71
ETWO
0.00%
$3.30
SCWO
+32.07%
$0.48
SNAP
+1.28%
$7.87
BAC
+1.29%
$51.76
RIVN
+1.31%
$13.09
BTE
+5.72%
$2.40
APLD
+9.01%
$33.38
DNUT
+1.98%
$4.11
HOOD
+5.58%
$134.33
LUMN
+10.65%
$7.79
VALE
-0.52%
$11.46
AFMD
-34.94%
$0.18
NCLH
-0.63%
$23.48
ERIC
-0.31%
$9.48
CLSK
+4.80%
$17.67
KDLY
+10.41%
$0.79
ELBM
+3.61%
$1.72
NAKA
+10.41%
$0.79
YYAI
-50.60%
$0.09
BYND
-20.67%
$2.84
SCNX
+354.94%
$2.60
YDKG
+5.58%
$0.07
F
-0.72%
$12.34
CGBS
-39.47%
$0.03
VHAI
0.00%
$0.00
RGTI
+9.80%
$39.59
AIRE
+38.18%
$0.98
RIG
+13.74%
$3.89
TSLA
+2.28%
$448.98
INTC
+3.35%
$38.15
BURU
-5.27%
$0.34
VTYX
+70.98%
$6.60
NOK
+11.17%
$6.17
QBTS
+13.81%
$31.06
NVDA
+1.04%
$182.16
T
-3.63%
$24.62
ADAP
-3.44%
$0.07
MSAI
+101.73%
$1.35
AAL
+5.62%
$12.77
BITF
+5.71%
$4.16
VIVK
+5.68%
$0.26
WTO
-7.04%
$0.06
IONZ
-14.59%
$3.98
AREB
+75.34%
$3.77
AXDX
-61.36%
$0.03
DNN
+0.36%
$2.73
IONQ
+7.06%
$59.37
PLUG
-1.36%
$2.88
ABEV
+0.45%
$2.21
SMCI
-8.72%
$47.92
QUBT
+7.19%
$15.94
TLRY
+2.06%
$1.48
VZ
-3.51%
$38.40
RGTZ
-20.27%
$14.90
GRAB
+1.77%
$5.72
SOFI
+3.27%
$28.08
RBNE
+7.87%
$1.37
BBD
+1.51%
$3.35
JOBY
+1.29%
$15.67
RF
-0.04%
$24.10
CAN
+3.22%
$1.76
ETHD
-3.17%
$3.97
ACHR
+0.46%
$10.91
QS
+7.95%
$14.66
RMBL
+60.50%
$3.21
SGBX
+29.82%
$2.96
AMD
+2.06%
$234.99
BTG
+0.38%
$5.23
ADD
-25.47%
$0.05
VLY
+4.24%
$10.56
ONDS
+4.74%
$7.06
GPUS
-0.28%
$0.38
PLTR
+2.84%
$180.48
LAES
+5.92%
$5.72
RXRX
-0.34%
$5.73
SRM
+53.27%
$10.30
CIFR
+7.10%
$17.25
PFE
-0.20%
$24.67
TNGX
-13.04%
$7.53
UUUU
-6.50%
$21.26
BTBT
+3.62%
$3.72
AAPL
+0.43%
$259.58
MARA
+0.36%
$19.22
AMC
-0.72%
$2.73
DVLT
+5.14%
$2.25
WBD
+3.50%
$21.25
AMZN
+1.44%
$221.09
IREN
+7.77%
$55.86
HPE
+0.43%
$23.19
PBR
+0.93%
$11.84
NIO
+0.73%
$6.89
IBIO
-8.63%
$1.27
CUTR
-10.19%
$0.09
KMI
-4.75%
$26.25
NVTS
+0.03%
$13.61
WLGS
-5.57%
$0.04
SOUN
+2.70%
$18.23
LUV
-6.25%
$31.65
RR
+7.11%
$5.42
TE
-9.73%
$3.71
ETWO
0.00%
$3.30
SCWO
+32.07%
$0.48
SNAP
+1.28%
$7.87
BAC
+1.29%
$51.76
RIVN
+1.31%
$13.09
BTE
+5.72%
$2.40
APLD
+9.01%
$33.38
DNUT
+1.98%
$4.11
HOOD
+5.58%
$134.33
LUMN
+10.65%
$7.79
VALE
-0.52%
$11.46
AFMD
-34.94%
$0.18
NCLH
-0.63%
$23.48
ERIC
-0.31%
$9.48
CLSK
+4.80%
$17.67
KDLY
+10.41%
$0.79
ELBM
+3.61%
$1.72
NAKA
+10.41%
$0.79
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.